IMMNOV.STIMMNOV.STSTO
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +191.67% | -10.90% | +5.88% | -57.02% | -22.20% |
| Gross Profit Growth | +0.00% | -10.90% | +5.88% | -72.34% | +0.00% |
| EBITDA Growth | +0.00% | -10045.30% | +0.00% | +0.00% | -457.19% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | -664.40% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | -280.66% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | -280.66% |
| Weighted Average Shares Growth | +274.74% | +433.08% | +226.70% | +445.90% | +211.84% |
| Weighted Average Shares Diluted Growth | +274.74% | +433.08% | +557.64% | +745.80% | +211.84% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +90.61% | +0.00% | -40.66% | -38.16% | +2.43% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -66.52% | -38.35% | -40.19% | -40.32% | +166.97% |
| Book Value per Share Growth | -95.36% | -87.44% | -72.44% | +0.00% | +78.21% |
| Debt Growth | -84.13% | -98.75% | -94.64% | +1261.36% | +26.03% |
| R&D Expense Growth | -100.00% | -100.00% | +30.11% | +0.00% | +0.00% |
| SG&A Expenses Growth | +52.59% | -132.50% | +0.00% | +0.00% | -114.06% |